HA
ABBV icon

Helium Advisors’s AbbVie ABBV Stock Holding History

Helium Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
1,168
+3
+0.3% +$645 0.24% 84
2026
Q1 		$253K Sell
1,165
-5
-0.4% -$1.11K 0.24% 82
2025
Q4 		$267K Buy
1,170
+26
+2% +$5.92K 0.27% 68
2025
Q3 		$265K Sell
1,144
-849
-43% -$173K 0.22% 70
2025
Q2 		$370K Buy
1,993
+323
+19% +$60K 0.23% 69
2025
Q1 		$350K Buy
1,670
+7
+0.4% +$1.36K 0.25% 61
2024
Q4 		$295K Buy
+1,663
New +$306K 0.23% 67

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Helium Advisors's ABBV Position: Q2 2026 in Review

Helium Advisors increased its AbbVie (ABBV) stake by 0.26% in Q2 2026, buying an estimated $645 and bringing the position to 1,168 shares worth $294K. The position accounts for 0.24% of the portfolio, ranked #84.

Helium Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $370K in Q2 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Helium Advisors held 1,168 shares of AbbVie worth $294K as of Q2 2026.
  • Helium Advisors bought 3 AbbVie shares in Q2 2026, an estimated $645.
  • AbbVie made up 0.24% of Helium Advisors's portfolio in Q2 2026, its #84 holding.
  • Helium Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Helium Advisors's AbbVie position peaked at $370K in Q2 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Helium Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.